Page 17 - Virtual Edition News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Active Biotech Year-end report January - December 2020 Fourth quarter in brief Tasquinimod The clinical study in multiple myeloma was presented at an oral poster session at the virtual American Society of Hematology (ASH) 2020 meeting in December Patent granted in China in October regarding treatment of multiple myeloma Patent granted in Europe in November regarding use of tasquinimod in combination with immunotherapy Laquinimod Naptumomab Corporate A Capital Markets Day was held on November 24 The clinical strategy and projected development milestones presented to the market in November ...

Library calendar for Feb. 3-9, 2021 Ocala Star-Banner TODAY Celebrate Every Day: 10 a.m.- 6 p.m. Reddick Public Library, 15150 NW Gainesville Road, Reddick. Free. From Dragon Appreciation Day to Crossword Puzzle Day, we are celebrating! There’s something happening every day this branch is open, so check with us and celebrate!  All ages welcome. Call 352-438-2566 to register. Shake, Rattle and Read: 10:15 and 11:15 a.m. Headquarters-Ocala Public Library, 2720 E. Silver Springs Blvd., Ocala. Free. A variety of stories, songs and activities for young children with caregivers.  Ages 5 a...

Share this article Share this article PALO ALTO, Calif., Feb. 2, 2021 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, today announced that a presentation of clinical study data on its investigational therapy KSI-301 will be made at the upcoming Angiogenesis, Exudation, and Degeneration 2021 – Virtual Edition meeting. Details of the presentation are as follows: Title: KSI-301: Intravitreal Antibody Biopolymer Conjugate that Demonstr...

  relapsed or refractory chronic lymphocytic leukaemia   progression after 12 months vs. 68% for comparators   AstraZeneca's Calquence (acalabrutinib), a next-generation, selective Bruton's tyrosine kinase (BTK) inhibitor, has been approved in Japan for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukaemia (CLL) (including small lymphocytic lymphoma [SLL]).   The approval by the Japanese Ministry of Health, Labour and Welfare was based on positive results from the ASCEND Phase III trial and a Phase I tr...

Artsline Artsline - Local Music, Dance, and Story to Challenge and Inspire Celebrate Tu B'Shevat or "Birthday of the Trees" with the Weinstein JCC as a day of ecological awareness. Artsline: Virtual Edition || January 25, 2021 “This is the sorcery of literature. We are healed by our stories.” ~Terry Tempest Williams As we as a nation heal from the events of the past month and the past year - from political division to racial division, from pandemic to ecological disaster - find the stories that heal. Your local arts and culture communities tell them every day, offering a source of concili...